Gamida Cell Ltd.
GMDADelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001600847
Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.
Superinvestors holding GMDA, Q1 2024
1 superinvestor reports holding Gamida Cell Ltd. on Form 13F, worth $54 in total. Weight is Gamida Cell Ltd.'s share of each 13F portfolio; actions compare shares with Q4 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | <0.1% | 1,484 | $54 | Reduced−99.9% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of GMDA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−99.9%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- ARK Invest (+51.1%)
Q3 2023
1 superinvestor holding at quarter end
- New
- ARK Invest
Q3 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−16.3%)
Q1 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+13.6%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+20.4%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−9.5%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+2.8%)